Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Int J Oncol. 2011 Jan 25;38(4):963–971. doi: 10.3892/ijo.2011.925

Table I.

JS-K increases the formation of acidic vesicular organelles in breast cancer cells but not in non-transformed or normal mammary epithelial cells.

Cells JS-K (μM) Acridine orange-stained positive cells (%)
MCF-7 0 4.7
1 19.3
5 29.2
MDA-MB-231a 0 3.1
1 13.6
5 39.6
SKBr-3a 0 4.8
1 29.7
5 45.8
MDA-MB-453a 0 4.4
1 17.9
5 41.1
MDA-MB-468b 0 2.6
5 18.4
HMECb 0 2.8
5 4.1
MCF-10Ac 0 7.1
5 9.3
Cells JS-43-126 (μM) Acridine orange-stained positive cells (%)
MDA-MB-231a 0 3.8
5 3.5
MDA-MB-453a 0 2.2
5 4.5
a

Breast cancer cells, plated at 1×105 cells per well in 6-well plates in 2 ml of DMEM/F12 medium containing 5% FBS, were treated with JS-K for 3 days and stained with acridine orange. The red fluorescence in the acridine orange-stained cells was detected by flow cytometry.

b

MDA-MB-468 and HMEC cells, plated at 4×105 cells per well in 6-well plates in 2 ml of HMEC medium containing bovine pituitary extract, were treated with JS-K for 3 days and stained with acridine orange. The red fluorescence in the acridine orange-stained cells was detected by flow cytometry.

c

MCF-10A cells, plated at 4×105 cells per well in 6-well plates in 2 ml of DMEM/F12 medium containing 10% FBS, 20 ng/ml epidermal growth factor, 20 ng/ml insulin-like growth factor-I, and 500 ng/ml hydrocortisone, were treated with JS-K for 3 days and stained with acridine orange. The red fluorescence in the acridine orange-stained cells was detected by flow cytometry.